Alston & Bird LLP
lobbying firm
Alston & Bird LLP's federal footprint as a lobbying firm — reported lobbying it billed or handled on behalf of the clients it represents (this is the firm's reported revenue for that work, not its own spending). Figures are as reported to the U.S. Senate (LDA).
Reported country: 🇺🇸 United States
Lobbying over time
| FY | Lobbying billed / handled (as firm) |
|---|---|
| 2022 | $9,780,000 |
| 2023 | $11,330,000 |
| 2024 | $10,920,000 |
| 2025 | $14,720,000 |
| 2026 | $20,000 |
Reported lobbying revenue for the clients Alston & Bird LLP represents — not the firm's own spending.
Clients represented
- Hologic, INC. $2,700,000 · 17 filings
- Redwood Holdings, LLC Fka Redwood Capital Investments $1,870,000 · 16 filings
- Future Of Pharmacy Coalition LLC $1,590,000 · 13 filings
- America'S Health Insurance Plans (Ahip) $1,360,000 · 17 filings
- American Clinical Laboratory Association $1,320,000 · 16 filings
- Medica $1,260,000 · 16 filings
- Travere Therapeutics $1,050,000 · 17 filings
- Cvs Health $940,000 · 17 filings
- Interpublic Group $900,000 · 15 filings
- Aflac, INC. $880,000 · 16 filings
Clients Alston & Bird LLP filed lobbying for, by reported amount billed/handled.
Issues
| Issue area | Worked |
|---|---|
| Health Issues | 822 |
| Medicare/Medicaid | 650 |
| Budget/Appropriations | 126 |
| Taxation/Internal Revenue Code | 123 |
| Medical/Disease Research/Clinical Labs | 48 |
| Labor Issues/Antitrust/Workplace | 40 |
| Education | 33 |
| Trade (domestic/foreign) | 33 |
| Agriculture | 31 |
| Veterans | 29 |
| Consumer Issues/Safety/Products | 26 |
| Immigration | 25 |
| Copyright/Patent/Trademark | 23 |
| Transportation | 20 |
| Pharmacy | 18 |
| Advertising | 16 |
| Welfare | 16 |
| Energy/Nuclear | 11 |
| Science/Technology | 11 |
| Telecommunications | 11 |
| Trucking/Shipping | 11 |
| Aviation/Airlines/Airports | 10 |
| Disaster Planning/Emergencies | 10 |
| Insurance | 10 |
| Housing | 9 |
| Small Business | 9 |
| Tobacco | 5 |
| Government Issues | 4 |
| Bankruptcy | 2 |
| Financial Institutions/Investments/Securities | 2 |
Issue areas across Alston & Bird LLP's filings, by activity count. Linked areas open the CivicGate issue page.
What they lobbied on
Reported activity from Senate LDA
-
FY2026 Medicare/Medicaid
General health care issues and Medicare policies/reimbursement issues that impact trauma centers. MISSION Zero and Trauma Grants appropriations.
-
FY2026 Health Issues
General health care issues and Medicare policies/reimbursement issues that impact trauma centers. MISSION Zero and Trauma Grants appropriations.
-
FY2025 Health Issues
Issues related to Medicare Advantage Health Plan.
-
FY2025 Medicare/Medicaid
General health care issues and Medicare reimbursement; issues concerning Medicare physician reimbursement and Pub. L. No. 119-21, One Big Beautiful Bill Act.
-
FY2025 Health Issues
General health care issues and Medicare graduate medical education. H.R.1153, Rural Physician Workforce Production Act of 2025. Vaccine policy issues.
-
FY2025 Agriculture
H-2A reform and Non-domicile commercial driving licensing issues.
-
FY2025 Transportation
H-2A reform and Non-domicile commercial driving licensing issues.
-
FY2025 Health Issues
General health care issues and Medicare policies/reimbursement issues that impact trauma centers. MISSION Zero and Trauma Grants appropriations.
Show 52 more activities
-
FY2025 Medicare/Medicaid
General health care issues and Medicare policies/reimbursement issues that impact trauma centers. MISSION Zero and Trauma Grants appropriations.
-
FY2025 Health Issues
Rural access to health care, and related appropriations issues.
-
FY2025 Medicare/Medicaid
Rural access to health care, and related appropriations issues.
-
FY2025 Health Issues
Hospital payment issues.
-
FY2025 Taxation/Internal Revenue Code
Monitoring and advocating tax issues affecting retirement savings and investments.
-
FY2025 Health Issues
Funding for community health center programs. Medicaid funding.
-
FY2025 Medicare/Medicaid
Funding for community health center programs. Medicaid funding.
-
FY2025 Medicare/Medicaid
Educating on general health insurance matters applicable to CareSource Mission.
-
FY2025 Taxation/Internal Revenue Code
Issues relating to the taxation of U.S. manufacturers with foreign operations.
-
FY2025 Trade (domestic/foreign)
Issues relating to tariffs and a potential new trade deal with Mexico.
-
FY2025 Health Issues
General health care issues related to Medicare coverage policies.
-
FY2025 Medicare/Medicaid
General health care issues related to Medicare coverage policies.
-
FY2025 Health Issues
Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.
-
FY2025 Health Issues
Federal research funding and general health care issues.
-
FY2025 Medical/Disease Research/Clinical Labs
Federal research funding and general health care issues. Artificial intelligence and Patent Eligibility Restoration Act of 2025.
-
FY2025 Medicare/Medicaid
Federal research funding and general health care issues. Medicare site neutrality reimbursement.
-
FY2025 Medicare/Medicaid
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Improving seniors timely access to care. H.R.1, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
-
FY2025 Health Issues
The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. Improving seniors timely access to care. NIH research funding.
-
FY2025 Budget/Appropriations
Funding for colorectal cancer screening and education. In general, policies impacting physician burden and sustaining the private practice physician model. NIH research funding.
-
FY2025 Health Issues
General health care issues and Medicare graduate medical education; H.R.1153, Rural Physician Workforce Production Act of 2025.
-
FY2025 Medicare/Medicaid
General health care issues and Medicare reimbursement; issues concerning rural emergency hospitals.
-
FY2025 Health Issues
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
-
FY2025 Medicare/Medicaid
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
-
FY2025 Budget/Appropriations
Issues related to increasing funding for Alzheimer's research and improving strategies for early detection and prevention; family and medical leave; Advanced Research Projects Agency-Health (ARPA-H); establishing a national Alzheimer's disease prevention goal.
-
FY2025 Health Issues
Issues related to increasing funding for Alzheimer's research and improving strategies for early detection and prevention; family and medical leave; Advanced Research Projects Agency-Health (ARPA-H); establishing a national Alzheimer's disease prevention goal.
-
FY2025 Medicare/Medicaid
Issues related to increasing funding for Alzheimer's research and improving strategies for early detection and prevention; Advanced Research Projects Agency-Health (ARPA-H); establishing a national Alzheimer's disease prevention goal.
-
FY2025 Health Issues
Issues related to academic medicine and research.
-
FY2025 Medical/Disease Research/Clinical Labs
Issues related to academic medicine and research.
-
FY2025 Medicare/Medicaid
Issues related to academic medicine and research.
-
FY2025 Medicare/Medicaid
General Medicare and Medicaid issues.
-
FY2025 Health Issues
General Medicare and Medicaid issues. Organ donation and transplantation issues.
-
FY2025 Health Issues
Advocacy and guidance on Medicare, Medicaid, and Social Security issues.
-
FY2025 Welfare
Advocacy and guidance on Medicare, Medicaid, and Social Security issues.
-
FY2025 Agriculture
Issues concerning agricultural labor reforms.
-
FY2025 Immigration
Issues concerning agricultural labor reforms.
-
FY2025 Labor Issues/Antitrust/Workplace
Issues concerning agricultural labor reforms.
-
FY2025 Health Issues
Issues related to healthcare reimbursement; issues related to payment and revenue integrity.
-
FY2025 Medicare/Medicaid
Issues related to healthcare reimbursement; issues related to payment and revenue integrity.
-
FY2025 Health Issues
General health care issues and Medicare policies/reimbursement issues that impact trauma centers. MISSION Zero and Trauma Grants appropriations.
-
FY2025 Medicare/Medicaid
General health care issues and Medicare policies/reimbursement issues that impact trauma centers. MISSION Zero and Trauma Grants appropriations.
-
FY2025 Taxation/Internal Revenue Code
Issues related to the taxation of publicly traded professional sports teams.
-
FY2025 Medicare/Medicaid
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B and site neutrality payment reforms.
-
FY2025 Health Issues
Advocacy and guidance on Medicare, Medicaid, and Social Security issues.
-
FY2025 Welfare
Advocacy and guidance on Medicare, Medicaid, and Social Security issues.
-
FY2025 Budget/Appropriations
Pub. L. No. 119-21, One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics.
-
FY2025 Health Issues
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
-
FY2025 Medical/Disease Research/Clinical Labs
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
-
FY2025 Medicare/Medicaid
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
-
FY2025 Trade (domestic/foreign)
Discussions regarding tariff proposals.
-
FY2025 Taxation/Internal Revenue Code
Pub. L. No. 119-21, One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of U.S. Tax Code.
-
FY2025 Health Issues
Issues concerning access to medical records for purposes of SSDI claims.
-
FY2025 Welfare
Issues concerning access to medical records for purposes of SSDI claims.
The specific issues and bills Alston & Bird LLP reported lobbying on, newest first. Bill references that CivicGate tracks link to the bill; others are shown as reported.